{"transactions":[{"id":482334,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Employee Stock Option (right to buy)","published_at":"2013-02-07T22:32:01.000Z","date":"2013-02-05","kind":"grant","acquired":true,"shares":45750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/05/2013."}],"balance_after":45750,"derivative":{"exercise_price":45.11,"expiration_date":"2023-02-04","underlying":"Common Stock","underlying_shares":45750},"source":{"system":"sec-edgar","filing":"0001209191-13-007127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113007127/doc4.xml","form_type":"4"}},{"id":482333,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2013-02-07T22:32:01.000Z","date":"2013-02-05","kind":"grant","acquired":true,"shares":10166,"price":0.01,"value":101.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant under 2006 Stock and Option Plan, vesting on 2/5/2017, subject to (i) acceleration of 50% of shares upon (a) receiving filing confirmation for an NDA for a combination regimen that includes both ivacaftor and a corrector compound or (b) receiving filing confirmation for an sNDA that would increase the number of patients with CF eligible for ivacaftor monotherapy, and (ii) acceleration of 50% of shares upon (a) the announcement of proof-of-concept data for a drug candidate other than an HCV, cystic fibrosis, influenza or JAK3 inhibition drug candidate or (b) reaching a specified net sales level over a twelve month period for our CF products."}],"balance_after":25382,"source":{"system":"sec-edgar","filing":"0001209191-13-007127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113007127/doc4.xml","form_type":"4"}},{"id":486144,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-11-19T21:35:52.000Z","date":"2012-11-16","kind":"sale","acquired":false,"shares":2033,"price":41.28,"value":83922.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $41.28 (range $41.01 to $41.82)."}],"balance_after":15216,"source":{"system":"sec-edgar","filing":"0001209191-12-053796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112053796/doc4.xml","form_type":"4"}},{"id":486143,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-11-19T21:35:52.000Z","date":"2012-11-15","kind":"sale","acquired":false,"shares":355,"price":40.59,"value":14409.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $40.59 (range $40.34 to $41.23)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":17249,"source":{"system":"sec-edgar","filing":"0001209191-12-053796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112053796/doc4.xml","form_type":"4"}},{"id":487687,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Employee Stock Option (right to buy)","published_at":"2012-09-21T20:25:57.000Z","date":"2012-09-19","kind":"exercise","acquired":false,"shares":3093,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":56907,"derivative":{"exercise_price":33,"expiration_date":"2019-10-21","underlying":"Common Stock","underlying_shares":3093},"source":{"system":"sec-edgar","filing":"0001209191-12-046401","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112046401/doc4.xml","form_type":"4"}},{"id":487686,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Employee Stock Option (right to buy)","published_at":"2012-09-21T20:25:57.000Z","date":"2012-09-19","kind":"exercise","acquired":false,"shares":954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":32.16,"expiration_date":"2018-07-23","underlying":"Common Stock","underlying_shares":954},"source":{"system":"sec-edgar","filing":"0001209191-12-046401","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112046401/doc4.xml","form_type":"4"}},{"id":487685,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-09-21T20:25:57.000Z","date":"2012-09-19","kind":"sale","acquired":false,"shares":4047,"price":57.61,"value":233147.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $57.61 (range $57.05 to $57.94)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":17249,"source":{"system":"sec-edgar","filing":"0001209191-12-046401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112046401/doc4.xml","form_type":"4"}},{"id":487684,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-09-21T20:25:57.000Z","date":"2012-09-19","kind":"exercise","acquired":true,"shares":3093,"price":33,"value":102069.0,"ownership":{"direct":true},"balance_after":21296,"source":{"system":"sec-edgar","filing":"0001209191-12-046401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112046401/doc4.xml","form_type":"4"}},{"id":487683,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-09-21T20:25:57.000Z","date":"2012-09-19","kind":"exercise","acquired":true,"shares":954,"price":32.16,"value":30680.64,"ownership":{"direct":true},"balance_after":18203,"source":{"system":"sec-edgar","filing":"0001209191-12-046401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112046401/doc4.xml","form_type":"4"}},{"id":488623,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Employee Stock Option (right to buy)","published_at":"2012-08-20T21:20:25.000Z","date":"2012-08-16","kind":"exercise","acquired":false,"shares":953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":954,"derivative":{"exercise_price":32.16,"expiration_date":"2018-07-23","underlying":"Common Stock","underlying_shares":953},"source":{"system":"sec-edgar","filing":"0001209191-12-042654","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112042654/doc4.xml","form_type":"4"}},{"id":488622,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-08-20T21:20:25.000Z","date":"2012-08-16","kind":"sale","acquired":false,"shares":953,"price":55,"value":52415.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."}],"balance_after":17249,"source":{"system":"sec-edgar","filing":"0001209191-12-042654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112042654/doc4.xml","form_type":"4"}},{"id":488621,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-08-20T21:20:25.000Z","date":"2012-08-16","kind":"exercise","acquired":true,"shares":953,"price":32.16,"value":30648.48,"ownership":{"direct":true},"balance_after":18202,"source":{"system":"sec-edgar","filing":"0001209191-12-042654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112042654/doc4.xml","form_type":"4"}},{"id":489641,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Employee Stock Option (right to buy)","published_at":"2012-07-26T20:45:06.000Z","date":"2012-07-25","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 quarterly installments beginning on 10/25/2012."}],"balance_after":30500,"derivative":{"exercise_price":48.74,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0001209191-12-039155","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112039155/doc4.xml","form_type":"4"}},{"id":490920,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-05-29T20:26:57.000Z","date":"2012-05-24","kind":"sale","acquired":false,"shares":5106,"price":63.38,"value":323618.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $63.38 (range $63.06 to $63.62)."}],"balance_after":17249,"source":{"system":"sec-edgar","filing":"0001209191-12-031019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112031019/doc4.xml","form_type":"4"}},{"id":490919,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-05-29T20:26:57.000Z","date":"2012-05-24","kind":"sale","acquired":false,"shares":900,"price":62.74,"value":56466.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $62.74 (range $62.25 to $62.99)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":22355,"source":{"system":"sec-edgar","filing":"0001209191-12-031019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112031019/doc4.xml","form_type":"4"}},{"id":491216,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-05-16T20:35:20.000Z","date":"2012-05-15","kind":"sale","acquired":false,"shares":37,"price":65.24,"value":2413.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."}],"balance_after":23255,"source":{"system":"sec-edgar","filing":"0001209191-12-028594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112028594/doc4.xml","form_type":"4"}},{"id":491567,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2012-05-09T20:36:05.000Z","date":"2012-05-07","kind":"exercise","acquired":false,"shares":3813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":18.93,"expiration_date":"2018-02-06","underlying":"Common Stock","underlying_shares":3813},"source":{"system":"sec-edgar","filing":"0001209191-12-027015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112027015/doc4.xml","form_type":"4"}},{"id":491566,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2012-05-09T20:36:05.000Z","date":"2012-05-07","kind":"exercise","acquired":false,"shares":28593,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1907,"derivative":{"exercise_price":32.16,"exercise_date":"2008-10-24","expiration_date":"2018-07-23","underlying":"Common Stock","underlying_shares":28593},"source":{"system":"sec-edgar","filing":"0001209191-12-027015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112027015/doc4.xml","form_type":"4"}},{"id":491565,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-05-09T20:36:05.000Z","date":"2012-05-07","kind":"sale","acquired":false,"shares":14297,"price":57.5,"value":822077.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."}],"balance_after":23255,"source":{"system":"sec-edgar","filing":"0001209191-12-027015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112027015/doc4.xml","form_type":"4"}},{"id":491564,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-05-09T20:36:05.000Z","date":"2012-05-07","kind":"sale","acquired":false,"shares":7187,"price":52.13,"value":374658.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."}],"balance_after":37552,"source":{"system":"sec-edgar","filing":"0001209191-12-027015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112027015/doc4.xml","form_type":"4"}},{"id":491563,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-05-09T20:36:05.000Z","date":"2012-05-07","kind":"sale","acquired":false,"shares":16242,"price":55,"value":893310.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."}],"balance_after":44739,"source":{"system":"sec-edgar","filing":"0001209191-12-027015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112027015/doc4.xml","form_type":"4"}},{"id":491562,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-05-09T20:36:05.000Z","date":"2012-05-07","kind":"exercise","acquired":true,"shares":3813,"price":32.16,"value":122626.08,"ownership":{"direct":true},"balance_after":60981,"source":{"system":"sec-edgar","filing":"0001209191-12-027015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112027015/doc4.xml","form_type":"4"}},{"id":491561,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-05-09T20:36:05.000Z","date":"2012-05-07","kind":"exercise","acquired":true,"shares":28593,"price":32.16,"value":919550.88,"ownership":{"direct":true},"balance_after":57168,"source":{"system":"sec-edgar","filing":"0001209191-12-027015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112027015/doc4.xml","form_type":"4"}},{"id":496260,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-02-09T21:09:15.000Z","date":"2012-02-08","kind":"sale","acquired":false,"shares":8133,"price":36.8,"value":299294.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $36.80 (range $36.50 to $37.25)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":28575,"source":{"system":"sec-edgar","filing":"0001209191-12-008686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112008686/doc4.xml","form_type":"4"}},{"id":496571,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2012-02-06T21:06:14.000Z","date":"2012-02-02","kind":"grant","acquired":true,"shares":45750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/02/2012."}],"balance_after":45750,"derivative":{"exercise_price":37.86,"exercise_date":"2012-05-02","expiration_date":"2022-02-01","underlying":"Common Stock","underlying_shares":45750},"source":{"system":"sec-edgar","filing":"0001209191-12-007774","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112007774/doc4.xml","form_type":"4"}},{"id":496570,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-02-06T21:06:14.000Z","date":"2012-02-02","kind":"grant","acquired":true,"shares":10166,"price":0.01,"value":101.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant under 2006 Stock and Option Plan, vesting on 2/2/2016, subject to (i) earlier acceleration of 50% of shares upon (A) reaching specified aggregate product and royalty sales levels or (B) completing enrollment of a pivotal trial in two distinct disease indications other than HCV and cystic fibrosis and (ii) earlier acceleration of 50% of shares upon receiving filing confirmation for an NDA for an all-oral regimen for the treatment of HCV infection."}],"balance_after":36708,"source":{"system":"sec-edgar","filing":"0001209191-12-007774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112007774/doc4.xml","form_type":"4"}},{"id":497610,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2012-01-23T21:36:17.000Z","date":"2012-01-19","kind":"sale","acquired":false,"shares":10166,"price":37,"value":376142.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $37.00 (range $36.84 to $37.15)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":26542,"source":{"system":"sec-edgar","filing":"0001209191-12-004850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112004850/doc4.xml","form_type":"4"}},{"id":501079,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Options","published_at":"2011-09-09T17:22:18.000Z","date":"2011-08-31","kind":"exercise","acquired":false,"shares":953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/07/2008, except that the first quarterly vesting occurred on May 15, 2008."}],"balance_after":3813,"derivative":{"exercise_price":18.93,"exercise_date":"2008-05-15","expiration_date":"2018-05-14","underlying":"Common Stock","underlying_shares":953},"source":{"system":"sec-edgar","filing":"0001209191-11-047231","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111047231/doc4.xml","form_type":"4"}},{"id":501078,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-09-09T17:22:18.000Z","date":"2011-09-08","kind":"sale","acquired":false,"shares":953,"price":47.5,"value":45267.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."}],"balance_after":36708,"source":{"system":"sec-edgar","filing":"0001209191-11-047231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111047231/doc4.xml","form_type":"4"}},{"id":501077,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-09-09T17:22:18.000Z","date":"2011-09-08","kind":"exercise","acquired":true,"shares":953,"price":18.93,"value":18040.29,"ownership":{"direct":true},"balance_after":37661,"source":{"system":"sec-edgar","filing":"0001209191-11-047231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111047231/doc4.xml","form_type":"4"}},{"id":501219,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Options","published_at":"2011-09-01T18:15:55.000Z","date":"2011-08-31","kind":"exercise","acquired":false,"shares":953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/07/2008, except that the first quarterly vesting occurred on May 15, 2008."}],"balance_after":953,"derivative":{"exercise_price":18.93,"exercise_date":"2008-05-15","expiration_date":"2018-05-14","underlying":"Common Stock","underlying_shares":953},"source":{"system":"sec-edgar","filing":"0001209191-11-046264","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111046264/doc4.xml","form_type":"4"}},{"id":501218,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-09-01T18:15:55.000Z","date":"2011-08-31","kind":"sale","acquired":false,"shares":800,"price":46.17,"value":36936.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $46.17 (range $46.00 to $46.44)."}],"balance_after":36708,"source":{"system":"sec-edgar","filing":"0001209191-11-046264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111046264/doc4.xml","form_type":"4"}},{"id":501217,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-09-01T18:15:55.000Z","date":"2011-08-31","kind":"sale","acquired":false,"shares":1527,"price":45.63,"value":69677.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $45.63 (range $45.17 to $45.96)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":37508,"source":{"system":"sec-edgar","filing":"0001209191-11-046264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111046264/doc4.xml","form_type":"4"}},{"id":501216,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-09-01T18:15:55.000Z","date":"2011-08-31","kind":"exercise","acquired":true,"shares":953,"price":18.93,"value":18040.29,"ownership":{"direct":true},"balance_after":39035,"source":{"system":"sec-edgar","filing":"0001209191-11-046264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111046264/doc4.xml","form_type":"4"}},{"id":502079,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2011-08-01T18:31:28.000Z","date":"2011-07-29","kind":"exercise","acquired":false,"shares":954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":28.84,"expiration_date":"2021-07-12","underlying":"Common Stock","underlying_shares":954},"source":{"system":"sec-edgar","filing":"0001209191-11-041693","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111041693/doc4.xml","form_type":"4"}},{"id":502078,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-08-01T18:31:28.000Z","date":"2011-07-29","kind":"sale","acquired":false,"shares":954,"price":52.5,"value":50085.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."}],"balance_after":38082,"source":{"system":"sec-edgar","filing":"0001209191-11-041693","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111041693/doc4.xml","form_type":"4"}},{"id":502077,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-08-01T18:31:28.000Z","date":"2011-07-29","kind":"exercise","acquired":true,"shares":954,"price":28.84,"value":27513.36,"ownership":{"direct":true},"balance_after":39036,"source":{"system":"sec-edgar","filing":"0001209191-11-041693","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111041693/doc4.xml","form_type":"4"}},{"id":502507,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2011-07-14T19:08:45.000Z","date":"2011-07-13","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/13/2011."}],"balance_after":30500,"derivative":{"exercise_price":51.75,"exercise_date":"2011-10-13","expiration_date":"2021-07-12","underlying":"Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0001209191-11-039507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111039507/doc4.xml","form_type":"4"}},{"id":502570,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2011-07-13T19:02:12.000Z","date":"2011-07-12","kind":"exercise","acquired":false,"shares":953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Right to buy under 2006 Stock and Option Plan vesting in 16 quarterly installments from 07/12/2007."}],"balance_after":954,"derivative":{"exercise_price":28.84,"exercise_date":"2007-10-12","expiration_date":"2017-07-11","underlying":"Common Stock","underlying_shares":953},"source":{"system":"sec-edgar","filing":"0001209191-11-039367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111039367/doc4.xml","form_type":"4"}},{"id":502569,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-07-13T19:02:12.000Z","date":"2011-07-12","kind":"sale","acquired":false,"shares":953,"price":51.22,"value":48812.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $51.22 (range $50.21 to $51.56)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":38082,"source":{"system":"sec-edgar","filing":"0001209191-11-039367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111039367/doc4.xml","form_type":"4"}},{"id":502568,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-07-13T19:02:12.000Z","date":"2011-07-12","kind":"exercise","acquired":true,"shares":953,"price":28.84,"value":27484.52,"ownership":{"direct":true},"balance_after":39035,"source":{"system":"sec-edgar","filing":"0001209191-11-039367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111039367/doc4.xml","form_type":"4"}},{"id":503660,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-05-26T19:57:56.000Z","date":"2011-05-25","kind":"sale","acquired":false,"shares":2200,"price":56.22,"value":123684.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $56.22 (range $56.04 to $56.57)."}],"balance_after":38082,"source":{"system":"sec-edgar","filing":"0001209191-11-031210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111031210/doc4.xml","form_type":"4"}},{"id":503659,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-05-26T19:57:56.000Z","date":"2011-05-25","kind":"sale","acquired":false,"shares":1960,"price":55.49,"value":108760.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $55.49 (range $55.05 to $55.92)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":40212,"source":{"system":"sec-edgar","filing":"0001209191-11-031210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111031210/doc4.xml","form_type":"4"}},{"id":503926,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-05-18T17:47:01.000Z","date":"2011-05-17","kind":"sale","acquired":false,"shares":224,"price":57.38,"value":12853.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $57.38 (range $57.15 to $57.56)."}],"balance_after":42242,"source":{"system":"sec-edgar","filing":"0001209191-11-029275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111029275/doc4.xml","form_type":"4"}},{"id":503925,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-05-18T17:47:01.000Z","date":"2011-05-17","kind":"sale","acquired":false,"shares":439,"price":56.62,"value":24856.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $56.62 (range $56.33 to $56.99)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":42466,"source":{"system":"sec-edgar","filing":"0001209191-11-029275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111029275/doc4.xml","form_type":"4"}},{"id":504450,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2011-05-10T20:10:15.000Z","date":"2011-05-09","kind":"exercise","acquired":false,"shares":1906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Right to buy under 2006 Stock and Option Plan vesting in 16 quarterly installments from 02/07/2008."}],"balance_after":5719,"derivative":{"exercise_price":18.93,"exercise_date":"2008-08-15","expiration_date":"2018-05-14","underlying":"Common Stock","underlying_shares":1906},"source":{"system":"sec-edgar","filing":"0001209191-11-027255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111027255/doc4.xml","form_type":"4"}},{"id":504449,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-05-10T20:10:15.000Z","date":"2011-05-09","kind":"sale","acquired":false,"shares":1076,"price":57.53,"value":61902.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $57.53 (range $57.13 to $57.90)."}],"balance_after":42242,"source":{"system":"sec-edgar","filing":"0001209191-11-027255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111027255/doc4.xml","form_type":"4"}},{"id":504448,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-05-10T20:10:15.000Z","date":"2011-05-09","kind":"sale","acquired":false,"shares":530,"price":56.69,"value":30045.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $56.69 (range $56.22 to $56.97)."}],"balance_after":43318,"source":{"system":"sec-edgar","filing":"0001209191-11-027255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111027255/doc4.xml","form_type":"4"}},{"id":504447,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-05-10T20:10:15.000Z","date":"2011-05-09","kind":"sale","acquired":false,"shares":300,"price":55.72,"value":16716.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $55.72 (range $55.52 to $55.90)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":43848,"source":{"system":"sec-edgar","filing":"0001209191-11-027255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111027255/doc4.xml","form_type":"4"}},{"id":504446,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-05-10T20:10:15.000Z","date":"2011-05-09","kind":"exercise","acquired":true,"shares":1906,"price":18.93,"value":36080.58,"ownership":{"direct":true},"balance_after":44148,"source":{"system":"sec-edgar","filing":"0001209191-11-027255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111027255/doc4.xml","form_type":"4"}},{"id":505389,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2011-04-27T20:09:29.000Z","date":"2011-04-27","kind":"exercise","acquired":false,"shares":14297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/12/2007."}],"balance_after":1907,"derivative":{"exercise_price":28.84,"exercise_date":"2007-10-12","expiration_date":"2017-07-11","underlying":"Common Stock","underlying_shares":14297},"source":{"system":"sec-edgar","filing":"0001209191-11-024585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111024585/doc4.xml","form_type":"4"}},{"id":505388,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-04-27T20:09:29.000Z","date":"2011-04-26","kind":"sale","acquired":false,"shares":14297,"price":50.5,"value":721998.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."}],"balance_after":42242,"source":{"system":"sec-edgar","filing":"0001209191-11-024585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111024585/doc4.xml","form_type":"4"}},{"id":505387,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-04-27T20:09:29.000Z","date":"2011-04-26","kind":"exercise","acquired":true,"shares":14297,"price":28.84,"value":412325.48,"ownership":{"direct":true},"balance_after":56539,"source":{"system":"sec-edgar","filing":"0001209191-11-024585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111024585/doc4.xml","form_type":"4"}},{"id":505441,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2011-04-26T19:40:40.000Z","date":"2011-04-25","kind":"exercise","acquired":false,"shares":953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 7/12/2007."}],"balance_after":16204,"derivative":{"exercise_price":28.84,"exercise_date":"2007-10-12","expiration_date":"2017-07-11","underlying":"Common Stock","underlying_shares":953},"source":{"system":"sec-edgar","filing":"0001209191-11-024395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111024395/doc4.xml","form_type":"4"}},{"id":505440,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-04-26T19:40:40.000Z","date":"2011-04-25","kind":"sale","acquired":false,"shares":953,"price":50,"value":47650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."}],"balance_after":42242,"source":{"system":"sec-edgar","filing":"0001209191-11-024395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111024395/doc4.xml","form_type":"4"}},{"id":505439,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-04-26T19:40:40.000Z","date":"2011-04-25","kind":"exercise","acquired":true,"shares":953,"price":28.84,"value":27484.52,"ownership":{"direct":true},"balance_after":43195,"source":{"system":"sec-edgar","filing":"0001209191-11-024395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111024395/doc4.xml","form_type":"4"}},{"id":506933,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2011-03-04T20:35:05.000Z","date":"2011-03-03","kind":"exercise","acquired":false,"shares":13343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/12/2007."}],"balance_after":17157,"derivative":{"exercise_price":28.84,"exercise_date":"2007-10-12","expiration_date":"2017-07-11","underlying":"Common Stock","underlying_shares":13343},"source":{"system":"sec-edgar","filing":"0001209191-11-015489","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111015489/doc4.xml","form_type":"4"}},{"id":506932,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-03-04T20:35:05.000Z","date":"2011-03-03","kind":"sale","acquired":false,"shares":13343,"price":50,"value":667150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."}],"balance_after":42242,"source":{"system":"sec-edgar","filing":"0001209191-11-015489","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111015489/doc4.xml","form_type":"4"}},{"id":506931,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-03-04T20:35:05.000Z","date":"2011-03-03","kind":"exercise","acquired":true,"shares":13343,"price":28.84,"value":384812.12,"ownership":{"direct":true},"balance_after":55585,"source":{"system":"sec-edgar","filing":"0001209191-11-015489","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111015489/doc4.xml","form_type":"4"}},{"id":507092,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2011-03-03T20:28:23.000Z","date":"2011-03-02","kind":"exercise","acquired":false,"shares":11438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/07/2008, except that the first quarterly vesting occurred on May 15, 2008."}],"balance_after":7625,"derivative":{"exercise_price":18.93,"exercise_date":"2008-05-15","expiration_date":"2018-02-06","underlying":"Common Stock","underlying_shares":11438},"source":{"system":"sec-edgar","filing":"0001209191-11-014962","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111014962/doc4.xml","form_type":"4"}},{"id":507091,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-03-03T20:28:23.000Z","date":"2011-03-02","kind":"sale","acquired":false,"shares":11438,"price":47.5,"value":543305.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."}],"balance_after":42242,"source":{"system":"sec-edgar","filing":"0001209191-11-014962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111014962/doc4.xml","form_type":"4"}},{"id":507090,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-03-03T20:28:23.000Z","date":"2011-03-02","kind":"exercise","acquired":true,"shares":11438,"price":18.93,"value":216521.34,"ownership":{"direct":true},"balance_after":53680,"source":{"system":"sec-edgar","filing":"0001209191-11-014962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111014962/doc4.xml","form_type":"4"}},{"id":507553,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2011-03-01T21:36:13.000Z","date":"2011-02-28","kind":"exercise","acquired":false,"shares":11437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/07/2008, except that the first quarterly vesting occurred on May 15, 2008."}],"balance_after":19063,"derivative":{"exercise_price":18.93,"exercise_date":"2008-05-15","expiration_date":"2018-02-06","underlying":"Common Stock","underlying_shares":11437},"source":{"system":"sec-edgar","filing":"0000875320-11-000020","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532011000020/edgar.xml","form_type":"4"}},{"id":507552,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-03-01T21:36:13.000Z","date":"2011-02-28","kind":"sale","acquired":false,"shares":11437,"price":45,"value":514665.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1."}],"balance_after":42242,"source":{"system":"sec-edgar","filing":"0000875320-11-000020","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532011000020/edgar.xml","form_type":"4"}},{"id":507551,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-03-01T21:36:13.000Z","date":"2011-02-28","kind":"exercise","acquired":true,"shares":11437,"price":18.93,"value":216502.41,"ownership":{"direct":true},"balance_after":53679,"source":{"system":"sec-edgar","filing":"0000875320-11-000020","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532011000020/edgar.xml","form_type":"4"}},{"id":509345,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2011-02-07T19:57:59.000Z","date":"2011-02-03","kind":"grant","acquired":true,"shares":45750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/03/2011."}],"balance_after":45750,"derivative":{"exercise_price":38.8,"exercise_date":"2011-05-03","expiration_date":"2021-02-02","underlying":"Common Stock","underlying_shares":45750},"source":{"system":"sec-edgar","filing":"0000875320-11-000013","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532011000013/edgar.xml","form_type":"4"}},{"id":509344,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-02-07T19:57:59.000Z","date":"2011-02-03","kind":"grant","acquired":true,"shares":10166,"price":0.01,"value":101.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant under 2006 Stock and Option Plan, vesting on 2/3/2015, subject to (i) earlier acceleration of 50% of shares upon (A) receiving U.S. and E.U. marketing approval for VX-770 or (B) reaching specified telaprevir sales levels during 18 months following its U.S. launch; and (ii) earlier acceleration of 50% of shares upon  (1) acceptance by the FDA of an NDA for a treatment regimen that includes telaprevir and VX-222; (2) initiation of a pivotal trial for a drug candidate for which the Company has U.S. commercialization rights in an indication that is not HCV infection or CF; or (3) reaching specified telaprevir sales levels during 18 months following its U.S. launch."}],"balance_after":42242,"source":{"system":"sec-edgar","filing":"0000875320-11-000013","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532011000013/edgar.xml","form_type":"4"}},{"id":510328,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-01-26T20:23:45.000Z","date":"2011-01-25","kind":"sale","acquired":false,"shares":471,"price":40.78,"value":19207.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan established under Rule 10b5-1."}],"balance_after":32076,"source":{"system":"sec-edgar","filing":"0000875320-11-000006","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532011000006/edgar.xml","form_type":"4"}},{"id":510337,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2011-01-25T18:11:27.000Z","date":"2011-01-21","kind":"sale","acquired":false,"shares":1709,"price":39.93,"value":68240.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan established under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $39.93 (range $39.81 to 40.02)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":32547,"source":{"system":"sec-edgar","filing":"0000875320-11-000005","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532011000005/edgar.xml","form_type":"4"}},{"id":515863,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2010-08-03T16:08:03.000Z","date":"2010-08-02","kind":"sale","acquired":false,"shares":307,"price":34.17,"value":10490.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan established under Rule 10b5-1."}],"balance_after":34256,"source":{"system":"sec-edgar","filing":"0000875320-10-000048","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532010000048/edgar.xml","form_type":"4"}},{"id":516193,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Options","published_at":"2010-07-16T19:55:53.000Z","date":"2010-07-14","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/14/2010."}],"balance_after":30500,"derivative":{"exercise_price":33.82,"exercise_date":"2010-10-14","expiration_date":"2020-07-13","underlying":"Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0000875320-10-000044","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532010000044/edgar.xml","form_type":"4"}},{"id":516537,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2010-06-29T18:50:30.000Z","date":"2010-06-28","kind":"sale","acquired":false,"shares":876,"price":34.73,"value":30423.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan established under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $34.73 (range $34.40 to $35.11)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":34563,"source":{"system":"sec-edgar","filing":"0000875320-10-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532010000035/edgar.xml","form_type":"4"}},{"id":523498,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2010-02-08T18:36:30.000Z","date":"2010-02-04","kind":"grant","acquired":true,"shares":76250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock option under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments over four years."}],"balance_after":76250,"derivative":{"exercise_price":39.05,"exercise_date":"2010-05-04","expiration_date":"2020-02-03","underlying":"Common Stock","underlying_shares":76250},"source":{"system":"sec-edgar","filing":"0000875320-10-000005","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532010000005/edgar.xml","form_type":"4"}},{"id":523497,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2010-02-08T18:36:30.000Z","date":"2010-02-04","kind":"grant","acquired":true,"shares":10166,"price":0.01,"value":101.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant under 2006 Stock and Option Plan, vesting on 2/4/2014, subject to 50% acceleration upon receiving U.S. marketing approval for telaprevir; and to 50% acceleration upon either (a) reaching specified telaprevir sales levels during 18 months following its U.S. launch or (b) launch of any additional drug beyond telaprevir prior to December 31, 2012."}],"balance_after":34563,"source":{"system":"sec-edgar","filing":"0000875320-10-000005","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532010000005/edgar.xml","form_type":"4"}},{"id":524534,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2010-01-27T22:05:33.000Z","date":"2010-01-26","kind":"sale","acquired":false,"shares":583,"price":39.48,"value":23016.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly's company approved trading plan established under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $39.48 (range $39.14 to $39.63)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":24397,"source":{"system":"sec-edgar","filing":"0000875320-10-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532010000003/edgar.xml","form_type":"4"}},{"id":526483,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2009-11-19T19:57:22.000Z","date":"2009-11-17","kind":"sale","acquired":false,"shares":875,"price":40.2,"value":35175.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan established under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $40.20 (range $39.85 to 40.44)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":24980,"source":{"system":"sec-edgar","filing":"0000875320-09-000097","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000097/edgar.xml","form_type":"4"}},{"id":527447,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Options","published_at":"2009-10-26T20:33:13.000Z","date":"2009-10-22","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option under 2006 Stock and Option Plan, vesting on 10/22/2014, subject to 20% acceleration upon receiving U.S. marketing approval for telaprevir; up to an additional 40% acceleration upon receiving U.S. approval for telaprevir if certain other performance goals are achieved; and 40% acceleration upon either (a) reaching specified telaprevir sales levels during 18 months following its U.S. launch or (b) launch of an additional drug beyond telaprevir prior to December 31, 2012."}],"balance_after":60000,"derivative":{"exercise_price":33,"exercise_date":"2014-10-22","expiration_date":"2019-10-21","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000875320-09-000090","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000090/edgar.xml","form_type":"4"}},{"id":529074,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2009-08-04T19:26:04.000Z","date":"2009-08-03","kind":"sale","acquired":false,"shares":319,"price":36.09,"value":11512.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Kelly's company approved trading plan established under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $36.09 (range $36.09 to $36.11)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Kelly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":24980,"source":{"system":"sec-edgar","filing":"0000875320-09-000074","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000074/edgar.xml","form_type":"4"}},{"id":529425,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2009-07-20T19:30:06.000Z","date":"2009-07-16","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/16/09."}],"balance_after":30500,"derivative":{"exercise_price":33.28,"exercise_date":"2009-10-16","expiration_date":"2019-07-15","underlying":"Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0000875320-09-000064","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000064/edgar.xml","form_type":"4"}},{"id":533587,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2009-02-06T21:27:40.000Z","date":"2009-02-05","kind":"grant","acquired":true,"shares":45750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/05/09."}],"balance_after":45750,"derivative":{"exercise_price":33.55,"exercise_date":"2009-05-05","expiration_date":"2019-02-04","underlying":"Common Stock","underlying_shares":45750},"source":{"system":"sec-edgar","filing":"0000875320-09-000010","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000010/edgar.xml","form_type":"4"}},{"id":533586,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2009-02-06T21:27:40.000Z","date":"2009-02-05","kind":"grant","acquired":true,"shares":10166,"price":0.01,"value":101.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 2006 Stock and Option Plan, vesting on 2/5/2013, subject to 50% acceleration upon filing a new drug application with the FDA for telaprevir and 50% acceleration upon the approval of a new drug application for telaprevir."}],"balance_after":25299,"source":{"system":"sec-edgar","filing":"0000875320-09-000010","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000010/edgar.xml","form_type":"4"}},{"id":538688,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Options","published_at":"2008-07-25T15:12:59.000Z","date":"2008-07-24","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008."}],"balance_after":30500,"derivative":{"exercise_price":32.16,"exercise_date":"2008-10-24","expiration_date":"2018-07-23","underlying":"Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0000875320-08-000059","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000059/edgar.xml","form_type":"4"}},{"id":559405,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2008-02-11T20:57:53.000Z","date":"2008-02-07","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 02/07/2008, subject to shareholder approval."}],"balance_after":3500,"derivative":{"exercise_price":18.93,"exercise_date":"2008-05-07","expiration_date":"2018-02-06","underlying":"Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0000875320-08-000010","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000010/edgar.xml","form_type":"4"}},{"id":559404,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Common Stock","published_at":"2008-02-11T20:57:53.000Z","date":"2008-02-07","kind":"grant","acquired":true,"shares":8133,"price":0.01,"value":81.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 2006 Stock and Option Plan, vesting on 2/7/2012, subject to acceleration upon achievement of certain performance-based milestones."}],"balance_after":15133,"source":{"system":"sec-edgar","filing":"0000875320-08-000010","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000010/edgar.xml","form_type":"4"}},{"id":575527,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16692,"kind":"person","name":"Kelly Lisa","position":1,"cik":"0001349077","reported_name":"Kelly Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option","published_at":"2007-07-16T17:51:14.000Z","date":"2007-07-12","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and option Plan, vesting in 16 equal quarterly installments from 07/12/2007."}],"balance_after":30500,"derivative":{"exercise_price":28.84,"exercise_date":"2007-10-12","expiration_date":"2017-07-11","underlying":"Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0000875320-07-000073","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000073/edgar.xml","form_type":"4"}}]}